- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07655765
The Effect of Breastfeeding Education Using the Pecha Kucha Technique on Breastfeeding Self-Efficacy and Breastfeeding Success in the Early Postpartum Period: A Randomized Controlled Trial
13. juni 2026 oppdatert av: YASEMİN AYDIN KARTAL, Saglik Bilimleri Universitesi
Breast milk is considered the most biologically appropriate source of nutrition, essential for the healthy growth and development of newborns.
Thanks to its optimal nutrients, immunological factors, and growth regulators, it not only meets nutritional needs but also protects against infections, reducing neonatal morbidity and mortality rates.
The Pecha Kucha presentation technique keeps presentations concise and dynamic, creating a fast-paced, light, and engaging experience.
It minimizes distractions and maximizes engagement.
Because there is no text to read in the Pecha Kucha technique, presenters are required to be more prepared and strive to create a coherent narrative, resulting in a flawless narrative.
Thus, the aim is to ensure the success and effectiveness of breastfeeding education with this technique, and ultimately, to promote breastfeeding education using the Pecha Kucha technique to healthcare professionals.
The population of this randomized, controlled experimental study consists of primiparous postpartum women who gave birth in the Obstetrics Department of the Physical Therapy Annex Building of the Gaziosmanpaşa Training and Research Hospital at the University of Health Sciences.
A power analysis was conducted using the G*Power package program, Version 3.1.9.4, to determine the sample size of the study.
Because no similar research was found in the literature, Cohen's medium effect size was chosen as the effect size, anticipating that tests assessing the difference between two independent groups would be used when examining the differences in variables between the control and intervention groups.
Accordingly, with 64 participants in the control group and 64 in the intervention group, a power of 80% was calculated at a significance level of 0.5 (medium) effect size and 0.05, and a minimum sample size of 128 was determined.
The study, planned using an experimental design, is planned to be conducted on two groups: an intervention and a control group.
Within the scope of the study, pretest data will be collected by administering the Breastfeeding Self-Efficacy Scale and the LATCH Breastfeeding Diagnostic and Assessment Scale, along with an introductory information form, to postpartum women who agree to participate in the study.
Studieoversikt
Studietype
Intervensjonell
Registrering (Antatt)
128
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Yasemin, AYDIN KARTAL, Prof. Dr.
- Telefonnummer: (0216) 777 87 77
- E-post: yasemin.aydin@sbu.edu.tr
Studer Kontakt Backup
- Navn: Merve N KAYADUMAN, Midwife
- Telefonnummer: (0216) 777 87 77
- E-post: merve.kydmn@gmail.com
Studiesteder
-
-
-
Istanbul, Tyrkia (Türkiye)
- Sağlık Bilimleri Üniversitesi, İstanbul,
-
Ta kontakt med:
- Merve N KAYADUMAN, Midwife
- Telefonnummer: (0216) 777 87 77
- E-post: merve.kydmn@gmail.com
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Ja
Beskrivelse
Inclusion Criteria:
- - Being primiparous
- Having a full-term, singleton birth
- Having a healthy newborn
- Having a spontaneous vaginal birth
Exclusion Criteria:
- Being multiparous (having given birth more than once)
- Having given birth preterm or postterm
- Having a mother or newborn with health problems
- Having had a multiple pregnancy
- Having had a cesarean section
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: intervention group
Mothers in the intervention group will receive breastfeeding training using the Pecha Kucha presentation technique at the first hour postpartum
|
Training will be provided using training material consisting of 20 slides, each lasting 20 seconds, prepared using the 'Pecha Kucha' technique, for a total duration of 6 minutes and 20 seconds.
|
|
Ingen inngripen: control group
Standard breastfeeding education, as part of the routine postpartum care practices of the Ministry of Health, will be given to the puerperal women in the control group at the first hour postpartum.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
introductory information form
Tidsramme: 10 minitus
|
This form, created by researchers based on literature, includes questions about the participants' age, high school graduation, their self-sufficiency against disasters, etc.
|
10 minitus
|
|
Breastfeeding Self-Efficacy Scale
Tidsramme: 10 minutes
|
The Breastfeeding Self-Efficacy Scale was developed by the National Institutes of Health (NIH) to assess mothers' breastfeeding self-efficacy levels.
The initial form consisted of 33 items.
In 2003, the scale was shortened to a 14-item version.Dennis recommends using the short form.
The Breastfeeding Self-Efficacy Short Form Scale is a 5-point Likert-type scale (1 = Not at all confident and 5 = Always confident).
The lowest possible score is 14, and the highest is 70.
As the score increases, breastfeeding self-efficacy also increases.
The validity and reliability of the scale in Turkey were conducted by Aluş Tokat, Okumus, and Dennis (2010).
The scale is a 5-point Likert-type scale, with scores ranging from Not at all confident (1 point) to Always confident (5 points).
The minimum possible score is 14, and the maximum score is 70.
There is no cut-off point for the scale.
A higher score indicates higher breastfeeding self-efficacy.
The Cronbach's alpha for the scale was found to be0.87
|
10 minutes
|
|
Latch Breastfeeding Diagnostic and Assessment Scale
Tidsramme: 10 minutes
|
The LATCH Breastfeeding Diagnostic Measurement Tool was developed by Jensen and colleagues (1994).
LATCH is a diagnostic tool created by simulating the Apgar scoring system in terms of its scoring method.
It is a quick and easy scale to evaluate (Jensen, Wallace 1994).
The Turkish validation of the tool was conducted by Demirhan in 1997, Koyun in 2001, and Yenal and Okumuş in 2003, and it was recommended as a reliable tool.
The lowest score obtained from the scale is 0, and the highest is 10.
A higher score indicates breastfeeding success.
The Cronbach's alpha value of the LATCH Breastfeeding Diagnostic Measurement Tool was found to be 0.95 by Yenal and Okumuş.
|
10 minutes
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
13. juni 2026
Primær fullføring (Antatt)
1. juli 2026
Studiet fullført (Antatt)
1. desember 2026
Datoer for studieregistrering
Først innsendt
13. juni 2026
Først innsendt som oppfylte QC-kriteriene
13. juni 2026
Først lagt ut (Faktiske)
18. juni 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
18. juni 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
13. juni 2026
Sist bekreftet
1. juni 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- SBU-AYDINKARTAL-KAYADUMAN
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .